Family Medicine 2020
DOI: 10.1007/978-1-4939-0779-3_174-1
|View full text |Cite
|
Sign up to set email alerts
|

Substance Use Disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 30 publications
0
2
0
Order By: Relevance
“…Selective serotonin reuptake inhibitors (SSRIs)-including fluoxetine, sertraline, and escitalopram-are considered first-line treatment for anxiety in children and adolescents. 17 Serotonin-norepinephrine reuptake inhibitors (SNRIs), such as duloxetine and venlafaxine, also have been shown to be effective.…”
Section: Treatment Is Multimodal and Multidisciplinarymentioning
confidence: 99%
See 1 more Smart Citation
“…Selective serotonin reuptake inhibitors (SSRIs)-including fluoxetine, sertraline, and escitalopram-are considered first-line treatment for anxiety in children and adolescents. 17 Serotonin-norepinephrine reuptake inhibitors (SNRIs), such as duloxetine and venlafaxine, also have been shown to be effective.…”
Section: Treatment Is Multimodal and Multidisciplinarymentioning
confidence: 99%
“…Duloxetine is the only medication approved by the US Food and Drug Administration (FDA) for treatment of generalized anxiety disorder in children ages 7 years and older. 17 SSRIs and SNRIs have a boxed warning from the FDA for increased suicidal thoughts and behaviors in children and adolescents. Although this risk is rare, it should be discussed with the patient and parent/guardian in order to obtain informed consent prior to treatment initiation.…”
Section: Treatment Is Multimodal and Multidisciplinarymentioning
confidence: 99%